Skip to content
healthcare.dev

codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [Lortuss EX]

RxNorm concept 1547607, branded drug (sbd). Prescribable name: Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution.

RxCUI
1547607
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1547607 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Lortuss EX (codeine phosphate 10 MG / guaiFENesin 100 MG / pseudoephedrine hydrochloride 30 MG) per 5 ML Oral Solution; Lortuss EX (codeine phosphate 10 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG) per 5 ML Oral Solution; codeine phosphate 2 MG/ML / guaiFENesin 20 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution [Lortuss EX]

Related concepts

Linked data

NDCs

  • 69036013016

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1547607 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1547607 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1547607. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.